Evidence map›Paper›PMID 30208597›Full record

ArticleInternational journal of molecular sciences2018

Clinical Evaluation of INNO-LiPA HPV Genotyping

Lan Xu, Elizaveta Padalko, Anja Oštrbenk, Mario Poljak, Marc Arbyn

Open access · goldAbstract readValidation Study
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The necessity and challenges of human papillomavirus testing for men.Frontiers in cellular and infection microbiology · 2025
    Review
  7. Evolving HPV diagnostics: current practice and future frontiers.Frontiers in cellular and infection microbiology · 2025
    Review
  8. Review
  9. Article
  10. p16Infectious agents and cancer · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Lan XuUnit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano (Previously Scientific Institute of Public Health), 1050 Brussels, Belgium. lan.xu@sciensano.be.ORCID 0000-0001-8654-679X
Elizaveta PadalkoDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, 9000 Gent, Belgium. elizaveta.padalko@uzgent.be.
Anja OštrbenkInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia. Anja.Ostrbenk@mf.uni-lj.si.
Mario PoljakInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia. Mario.Poljak@mf.uni-lj.si.ORCID 0000-0002-3216-7564
Marc ArbynUnit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano (Previously Scientific Institute of Public Health), 1050 Brussels, Belgium. marc.arbyn@sciensano.be.
Sciensano (Belgium) · BEUniversity of Ljubljana · SIGhent University Hospital · BE

Funding

Seventh Framework Programme 603019
6 · The paper itself

Abstract

In this diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping

Indexed as

AlphapapillomavirusCervix UteriDiagnostic Tests, RoutineDNA, ViralEarly Detection of CancerFemaleGenotyping TechniquesHumansPapillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsDNA, Viralcervical cancerclinical validationHPV genotypinghuman papillomavirusHybrid Capture 2INNO-LiPALinear ArrayVALGENT

Identifiers

PMID30208597
PMCPMC6165258
OpenAlexW2889779167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.